ArticleAnnals of translational medicine2020

Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report.

Yuling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.